Abrysvo Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Resp syncytial virus (RSV) vaccine

Indications/Uses

Active immunization of pregnant individuals at 32 through 36 wk gestational age for prevention of lower resp tract disease (LRTD) & severe LRTD caused by RSV in infants from birth through 6 mth. Active immunization for LRTD prevention in individuals ≥60 yr; 18-59 yr who are at increased risk for LRTD caused by RSV.

Click to view Abrysvo detailed prescribing information

Dosage/Direction for Use

IM 0.5 mL as single dose.

Click to view Abrysvo detailed prescribing information

Contraindications

Hypersensitivity.

Click to view Abrysvo detailed prescribing information

Special Precautions

Appropriate medical treatment must be immediately available in the event an anaphylactic reaction occurs following administration. Increased risk of Guillain-Barré syndrome during 42 days following vaccination. Syncope may occur; put procedures in place to avoid injury from fainting. Immunocompromised individuals including those receiving immunosuppressive therapy may have diminished immune response to Abrysvo. May not protect all vaccine recipients. Potential risk of preterm birth. Pregnant individuals <24 wk gestational age & those at increased risk of preterm birth. Lactation. Non-pregnant individuals <18 yr. Childn <10 yr.

Click to view Abrysvo detailed prescribing information

Use In Pregnancy & Lactation

Click to view Abrysvo detailed prescribing information

Adverse Reactions

Inj site pain, muscle pain. Pregnant individual & those 18-59 yr: Nausea. Pregnant individual & those ≥60 yr: Headache. Individual 18-59 yr: Joint pain. Individual ≥60 yr: Fatigue.

Click to view Abrysvo detailed prescribing information

Storage

View Abrysvo storage conditions for details to ensure optimal shelf-life.

Description

View Abrysvo description for details of the chemical structure and excipients (inactive components).

Action

View Abrysvo mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BX05 - respiratory syncytial virus vaccines ; Belongs to the class of other viral vaccines. Used for active immunization against respiratory syncytial virus.

Regulatory Classification

POM

Patient Counseling Information

View Abrysvo patient counselling information

Presentation/Packing

Form

Abrysvo powd for soln for inj 120 mcg/0.5 mL

Packing/Price

(+ 1 solvent in pre-filled syringe, 1 needle) 1's

Abrysvo

respiratory syncytial virus vaccine

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma